Therapy for advanced breast cancer is increasingly personalized, thanks to an array of molecularly targeted/endocrine therapies indicated for recurrent/stage IV disease. New classes of targeted agents have been recently introduced or are in development—notably the CDK4/6 inhibitors, PARP inhibitors, and immunotherapies approaches to advanced breast cancer. The complexities of today’s more personalized care pose multiple challenges to effective nurse navigation. Recorded from a presentation at the 2017 ONA Navigation Summit, this educational activity will provide learners with a detailed overview of current and emerging strategies for breast cancer, with a focus on individualized therapy. A review of the most recent clinical trial data for endocrine and molecularly targeted therapies will be provided, as will a discussion of new and emerging drug classes. The program faculty will also describe the ONN core competencies in the management of advanced breast cancer and how these can be fulfilled in actual practice.
This activity is intended for oncology nurse navigators, oncology nurses, care coordinators, and nurse practitioners.
At the conclusion of this activity, participants should be better able to:
Anticipate patient needs for tumor marker testing and other aspects of the workup in advanced breast cancer
Educate patients on the plans and rationales for using newer molecularly targeted/endocrine therapies in advanced breast cancer
Recognize and manage the toxicities of newer molecularly targeted/endocrine therapies as components of regimens for advanced breast cancer
Sustain patient-centric navigation through the complex pathways required in the increasingly personalized care of advanced breast cancer
Conflict of Interest Disclosure Policy
Individuals who have the ability to control or influence the content of a continuing education program provided by ONS are required to disclose all relevant financial interests or other relationships with commercial interests (entities that produce, market, resell, distribute or advocate for the use of specific healthcare goods or services consumed by or used on patients). A financial interest in a commercial company may include, but is not limited to, being an employee, owning stock or stock options, receiving a fee for consultation, serving on an organization’s speaker bureau or advisory board, receiving support for travel or receiving research funding.
Cynthia Cantril, RN, OCN, CBCN, MPH Director, Cancer Support Services/Patient Navigation Cancer Support Services Sutter Pacific Medical Foundation Santa Rosa, CA
Ms. Cantril is a consultant and is on the speakers’ bureau for Genentech.
Mayra Lima, MSN, ARNP, FNP-C Breast Cancer Treatment & Prevention Program Sylvester Comprehensive Cancer Center University of Miami Health System Plantation, FL
Ms. Lima is on the speakers’ bureaus for Genentech, Midatech Pharma, Myriad Genetics, and Pfizer Inc and is on the advisory board for Biotheranostics, Inc.
The planners of this program have not disclosed any pertinent financial relationships or conflicts of interest.
CNE Contact Hour(s)
The Oncology Nursing Society is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA. ONS is approved as a provider of continuing education by the California Board of Registered Nursing, Provider #2850.
The overall educational activity for 1.50 contact hours is jointly provided by the Oncology Nursing Society and Haymarket Medical Education. In order to receive credit for this activity, participants must watch the webcast, take the post-test, and submit a completed evaluation form.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of Oncology Nursing Society, Haymarket Medical Education, or Lilly. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
If you have any questions relating to the accreditation of this activity, please contact email@example.com.
To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.